SCHEMBL4026302

SCHEMBL4026302

CC(Cc1nccs1)C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.51
ALDH1A1 P00352 2/20 0.39
ACACB O00763 2/20 0.38
SLC6A3 Q01959 2/20 0.37
TSHR P16473 1/20 0.37
PKM P14618 1/20 0.36
LMNA P02545 1/20 0.36
XBP1 P17861 1/20 0.36
LRRK2 Q5S007 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
HSPA5 P11021 4/20 0.35
HSPA2 P54652 3/20 0.35
HSPA9 P38646 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13370727 0.84 FDPS (0.53) FDPSALDH1A1ACACBSLC6A3TSHR
SCHEMBL21299172 0.81 FDPS (0.53) FDPSALDH1A1ACACBSLC6A3TSHR
SCHEMBL6385699 0.81 FDPS (0.53) FDPSALDH1A1ACACBSLC6A3TSHR
SCHEMBL27461440 0.77 FDPS (0.49) FDPSALDH1A1ACACBSLC6A3TSHR
SCHEMBL2035542 0.76
SCHEMBL3407472 0.76
SCHEMBL14151613 0.76 ALDH1A1 (0.36) FDPSALDH1A1PKMLMNAXBP1
SCHEMBL17152211 0.76 ALDH1A1 (0.36) FDPSALDH1A1PKMLMNAXBP1
SCHEMBL8897017 0.75 FDPS (0.41) FDPSALDH1A1ACACBSLC6A3TSHR
SCHEMBL104654 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049507-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF Brystol-Myers Squibb Company (US) 2009-04-22 EP claimed
WO-2008021926-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO claimed
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP disclosed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO disclosed